Detection of
Calreticulin
Jak2
MPL
Mutation
Myelofibrosis
Myeloproliferative Diseases
Thrombocythemia
Journal
Mediterranean journal of hematology and infectious diseases
ISSN: 2035-3006
Titre abrégé: Mediterr J Hematol Infect Dis
Pays: Italy
ID NLM: 101530512
Informations de publication
Date de publication:
2019
2019
Historique:
received:
30
08
2018
accepted:
14
12
2018
entrez:
24
1
2019
pubmed:
24
1
2019
medline:
24
1
2019
Statut:
epublish
Résumé
Somatic mutations in the calreticulin gene ( MPN patient samples were collected from different clinical units and screened for Using this protocol we screened 173 MPN, Overall, our method could rapidly and cost-effectively detect the mutation status in a representative cohort of Greek patients; the mutation make-up in our group was not different from what has been published for other national groups.
Sections du résumé
BACKGROUND AND OBJECTIVES
OBJECTIVE
Somatic mutations in the calreticulin gene (
METHODS
METHODS
MPN patient samples were collected from different clinical units and screened for
RESULTS
RESULTS
Using this protocol we screened 173 MPN,
CONCLUSIONS
CONCLUSIONS
Overall, our method could rapidly and cost-effectively detect the mutation status in a representative cohort of Greek patients; the mutation make-up in our group was not different from what has been published for other national groups.
Identifiants
pubmed: 30671215
doi: 10.4084/MJHID.2019.009
pii: mjhid-11-1-e2019009
pmc: PMC6328041
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e2019009Déclaration de conflit d'intérêts
Competing interests: The authors have declared that no competing interests exist.
Références
Lancet. 2005 Mar 19-25;365(9464):1054-61
pubmed: 15781101
Nature. 2005 Apr 28;434(7037):1144-8
pubmed: 15793561
N Engl J Med. 2005 Apr 28;352(17):1779-90
pubmed: 15858187
Blood. 2005 Sep 15;106(6):2162-8
pubmed: 15920007
Blood. 2005 Nov 15;106(10):3377-9
pubmed: 16081687
PLoS Med. 2006 Jul;3(7):e270
pubmed: 16834459
N Engl J Med. 2007 Feb 1;356(5):459-68
pubmed: 17267906
Blood. 2008 Apr 15;111(8):4418
pubmed: 18398061
Blood. 2009 Jul 30;114(5):937-51
pubmed: 19357394
Hum Mutat. 2009 Jun;30(6):860-6
pubmed: 19418555
Br J Haematol. 2013 Jan;160(1):25-34
pubmed: 23057517
N Engl J Med. 2013 Dec 19;369(25):2379-90
pubmed: 24325356
N Engl J Med. 2013 Dec 19;369(25):2391-2405
pubmed: 24325359
Leukemia. 2014 May;28(5):1152-4
pubmed: 24365789
Blood. 2014 Mar 6;123(10):1544-51
pubmed: 24366362
Blood. 2014 Mar 6;123(10):1552-5
pubmed: 24371211
Leukemia. 2014 Jul;28(7):1472-7
pubmed: 24402162
Leukemia. 2014 Jul;28(7):1494-500
pubmed: 24496303
Leukemia. 2014 Sep;28(9):1811-8
pubmed: 24618731
Blood. 2014 Aug 14;124(7):1062-9
pubmed: 24986690
PLoS One. 2014 Jul 28;9(7):e103511
pubmed: 25068507
Leukemia. 2015 Jan;29(1):249-52
pubmed: 25212275
Ann Hematol. 2015 Mar;94(3):399-408
pubmed: 25349114
Leuk Res. 2015 Jan;39(1):82-7
pubmed: 25499808
Hematology Am Soc Hematol Educ Program. 2014 Dec 5;2014(1):287-96
pubmed: 25696868
Am J Clin Pathol. 2015 Nov;144(5):738-45
pubmed: 26486738
Am J Clin Pathol. 2015 Nov;144(5):746-55
pubmed: 26486739
Blood. 2016 May 19;127(20):2391-405
pubmed: 27069254
Stem Cell Investig. 2015 Aug 31;2:16
pubmed: 27358884
Nucleic Acids Res. 2017 Jan 4;45(D1):D777-D783
pubmed: 27899578